|Description||Carcinoembryonic antigen (CEA) is not useful diagnostically. Used mainly for the follow-up of colorectal cancer.|
|Indication||Limited value in diagnosis of cancer (lacks specificity). Role in monitoring therapy or recurrent disease. Used for colorectal, breast, bronchial and ovarian Ca.|
|Additional Info|| PLEASE NOTE: TEST CAN ONLY BE ADDED TO A SAMPLE WITHIN 8 HOURS OF COLLECTION|
|Interpretation||CEA >10 ug/L - probable malignancy. CEA >20 ug/L stage 3 or greater likely. NOTE that normal levels of CEA do not exclude malignancy. Reference range is higher in smokers.|
|Collection Conditions||No restrictions|
|Min. Vol||0.5 mL|
|Ref. Range (Male)||<8 ug/L |
|Ref. Range (Female)|| <8 ug/L |
|Ref. Range (Paed)|| na|
|Ref. Range Notes||<2.5 ug/L non smokers. <8 ug/L smokers.
|IP Acute TAT||Refer to Website|
|IP Routine TAT||Refer to Website|
|GP Acute TAT||- Contact Laboratory|
|GP Routine TAT||Refer to Website|
|Turnround Comment||Minimum re-test interval = 14 days|
Originally edited by : JHB. Review due on 23/05/2017 07:59:07. Published By Sylvia McLellan on 23/05/2016 07:59:07.